Hix Christopher M's Form 4 filing
Enovis CORP (ENOV) · filed Mar 1, 2022
- Accession no.
- 0001209191-22-014360
- Filed
- Mar 1, 2022
- Trade date
- Feb 25-28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $1.35M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hix Christopher MCIK 0001357529 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2022 | Common stock, par value $.001 | SSaleDisposed | −2,079 | $42.18 | −$87,692.22 | 108,509 | Direct | |
| Feb 25, 2022 | Common stock, par value $.001 | AGrant or awardAcquired | +67,915 | $0.00 | $0 | 176,424 | Direct | |
| Feb 28, 2022 | Common stock, par value $.001 | SSaleDisposed | −19,330 | $40.11F3 | −$775,326.3 | 157,094 | Direct | |
| Feb 28, 2022 | Common stock, par value $.001 | SSaleDisposed | −11,777 | $41.18F4 | −$484,976.86 | 145,317 | Direct | |
| Feb 28, 2022 | Common stock, par value $.001 | SSaleDisposed | −100 | $41.72 | −$4,172 | 145,217 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.69 to $40.67, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.54, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.